Literature DB >> 24599125

Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin.

Xiao Zhao1, Song Gao, He Ren, Wei Sun, Huan Zhang, Jianwei Sun, Shengyu Yang, Jihui Hao.   

Abstract

Because of the early onset of local invasion and distant metastasis, pancreatic ductal adenocarcinoma (PDAC) is the most lethal human malignant tumor, with a 5-year survival rate of less than 5%. In this study, we investigated the role of fascin, a prometastasis actin-bundling protein, in PDAC progression, invasion, and the molecular mechanisms underlying fascin overexpression in PDAC. Our data showed that the expression levels of fascin were higher in cancer tissues than in normal tissues, and fascin overexpression correlated with the PDAC differentiation and prognosis. Fascin overexpression promoted PDAC cell migration and invasion by elevating matrix metalloproteinase-2 (MMP-2) expression. Fascin regulated MMP-2 expression through protein kinase C and extracellular signal-regulated kinase. Importantly, our data showed that hypoxia induced fascin overexpression in PDAC cells by promoting the binding of hypoxia-inducible factor-1 (HIF-1) to a hypoxia response element on the fascin promoter and transactivating fascin mRNA transcription. Intriguingly, HIF-1α expression levels in PDAC patient specimens significantly correlated with fascin expression. Moreover, immunohistochemistry staining of consecutive sections demonstrated colocalization between HIF-1α and fascin in PDAC specimens, suggesting that hypoxia and HIF-1α were responsible for fascin overexpression in PDAC. When ectopically expressed, fascin was able to rescue PDAC cell invasion after HIF-1α knockdown. Our results demonstrated that fascin is a direct target gene of HIF-1. Our data suggested that the hypoxic tumor microenvironment in PDAC might promote invasion and metastasis by inducing fascin overexpression, and fascin might be targeted to block PDAC progression. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599125     DOI: 10.1158/0008-5472.CAN-13-3009

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  61 in total

1.  HIF-1 is a critical target of pancreatic cancer.

Authors:  Jihui Hao
Journal:  Oncoimmunology       Date:  2015-07-17       Impact factor: 8.110

2.  From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.

Authors:  Aikaterini F Giannopoulou; Athanassios D Velentzas; Athanasios K Anagnostopoulos; Adamantia Agalou; Nikos C Papandreou; Stamatia A Katarachia; Dimitra G Koumoundourou; Eumorphia G Konstantakou; Vasiliki I Pantazopoulou; Anastasios Delis; Maria T Michailidi; Dimitrios Valakos; Dimitris Chatzopoulos; Popi Syntichaki; Vassiliki A Iconomidou; Ourania E Tsitsilonis; Issidora S Papassideri; Gerassimos E Voutsinas; Polydefkis Hatzopoulos; Dimitris Thanos; Dimitris Beis; Ema Anastasiadou; George Th Tsangaris; Dimitrios J Stravopodis
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 3.  Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.

Authors:  Xi Hu; Fan Xia; Jiyoung Lee; Fangyuan Li; Xiaoyang Lu; Xiaozhen Zhuo; Guangjun Nie; Daishun Ling
Journal:  Adv Sci (Weinh)       Date:  2021-02-12       Impact factor: 16.806

4.  Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells.

Authors:  Cui-Juan Qian; Yi-Yi Chen; Xin Zhang; Fu-Qiang Liu; Ting-Ting Yue; Bei Ye; Jun Yao
Journal:  Oncol Lett       Date:  2016-09-07       Impact factor: 2.967

Review 5.  New targeted therapies in pancreatic cancer.

Authors:  Andrada Seicean; Livia Petrusel; Radu Seicean
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

6.  NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer.

Authors:  Iok In Christine Chio; Seyed Mehdi Jafarnejad; Mariano Ponz-Sarvise; Youngkyu Park; Keith Rivera; Wilhelm Palm; John Wilson; Vineet Sangar; Yuan Hao; Daniel Öhlund; Kevin Wright; Dea Filippini; Eun Jung Lee; Brandon Da Silva; Christina Schoepfer; John Erby Wilkinson; Jonathan M Buscaglia; Gina M DeNicola; Herve Tiriac; Molly Hammell; Howard C Crawford; Edward E Schmidt; Craig B Thompson; Darryl J Pappin; Nahum Sonenberg; David A Tuveson
Journal:  Cell       Date:  2016-07-28       Impact factor: 41.582

7.  Monoubiquitination Inhibits the Actin Bundling Activity of Fascin.

Authors:  Shengchen Lin; Shuang Lu; Mentor Mulaj; Bin Fang; Tyler Keeley; Lixin Wan; Jihui Hao; Martin Muschol; Jianwei Sun; Shengyu Yang
Journal:  J Biol Chem       Date:  2016-11-22       Impact factor: 5.157

8.  LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.

Authors:  Tiansuo Zhao; He Ren; Jing Li; Jing Chen; Huan Zhang; Wen Xin; Yan Sun; Lei Sun; Yongwei Yang; Junwei Sun; Xiuchao Wang; Song Gao; Chongbiao Huang; Huafeng Zhang; Shengyu Yang; Jihui Hao
Journal:  Cancer Res       Date:  2014-11-10       Impact factor: 12.701

Review 9.  Targeting hypoxic response for cancer therapy.

Authors:  Elisa Paolicchi; Federica Gemignani; Marija Krstic-Demonacos; Shoukat Dedhar; Luciano Mutti; Stefano Landi
Journal:  Oncotarget       Date:  2016-03-22

Review 10.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.